ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979

Univ. Of Pennsylvania Ordered to Review all NIH Research

October 11, 1985

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974